Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography

Chinese Medical Journal

Volumn 124, Issue 6, 2011, Pages 911-917

  Zhao, Quan Ming ^a   Feng, Ting Ting ^a   Zhao, Xin ^a   Xu, Zhan Min ^a   Liu, Yu ^b   Li, De Peng ^c   Li, Li Qin ^c   Su, Gong ^a   Zhang, Xiao Xia ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Second Artillery General Hospital   (China)

Author keywords

Angiography; Fluorine 18 fluorodeoxyglucose; Inflammation; Positron emission tomography; Vulnerable plaque

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CD14 ANTIGEN; CHOLESTEROL; FLUORODEOXYGLUCOSE F 18; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA MEDIA; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL COUNT; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; LIPID BLOOD LEVEL; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; AORTA; ATHEROSCLEROSIS; FLUORODEOXYGLUCOSE F18; MALE; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RABBITS;

EID: 79952850442     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.06.020     Document Type: Article

References (20)

1. Fuster V. Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2126-2146
2. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the unstable plaque. Prog Cardiovusc Dis 2002; 44: 349-356
3. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850
4. Pennell DJ, Bogren HG, Keegan J, Firmin DM, Underwood SR. Assessment of coronary artery stenosis by magnetic resonance imaging. Heart 1996; 75: 127-133
5. Johnstone MT, Botnar RM, Perez AS, Stewart R, Quist WC, Hamilton JA, et al. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol 2001; 21: 1556-1560
6. von Birgelen C, Slagcr CJ, Di Mario C, de Feyter PJ, Serruys PW. Volumetric intracoronary ultrasound: a new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis? Atherosclerosis l995; 118 Suppl: S103-S113.
7. Blankenberg FG, Strauss HW. Nuclear medicine applications in molecular imaging. Magn Reson Imaging 2002; 16: 352-361
8. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with 18F-fluorodcoxyglucosc positron emission tomography. Circulation 2002; 105: 2708-27 11.
9. Aikawa M, Sugiyama S, Hill CC, Voglic SJ, Rabkin E, Fukumoto Y, et al. Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma, Circulation 2002; 106: 1390-1396
10. Guo Y, Wang QZ, Tang BS, Zuo YF, Li FM, Jiang X, et al. Effects of aspirin on atherosclerosis and the cyclooxygenase-2 expression in atherosclerotic rabbits. Chin Med J 2006; 119: 1808-1814
11. Davies JR, Izquierdo-Garcia D, Rudd JH, Figg N, Richards HK, Bird JL, et al. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis. Int J Cardiovasc Imaging 2010; 26: 41-48
12. Li L, Cai XJ, Feng M, Rong YY, Zhang Y, Zhang M. Effect of adiponectin overexpression on stability of preexisting plaques by inducing prolyl-4-hydroxylase expression. Circ J 2010; 74: 552-559
13. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996; 7: 330-335
14. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671
15. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-599
16. Mollet NR, Cademartiri F, Nieman K, Saia F, Lemos PA, McFadden EP, et al. Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris. J Am Coll Cardiol 2004; 43: 2265-2270
17. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with 18F-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105: 2708-2711
18. Nishiyama Y, Yamamoto Y, Fukunaga K, Takinami H, Iwado Y, Satoh K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006; 47: 1571-1576
19. Laurberg JM, Olsen AK, Hansen SB, Bottcher M, Morrison M, Ricketts SA, et al. Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation. Atherosclerosis 2007; 192: 275-282
20. Nahrendorf M, Zhang H, Hembrador S, Panizzi P, Sosnovik DE, Aikawa E, et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008; 117: 379-387